Scholar rock presents exploratory responder analysis on efficacy data from the apitegromab topaz phase 2 trial at the child neurology society annual meeting

Cambridge, mass.--(business wire)--scholar rock announced a late breaker poster presentation as part of the 50th child neurology society (cns) annual meeting, occurring 9/29 - 10/2.

SRRK Ratings Summary

SRRK Quant Ranking